CXCL9 and ovarian carcinoma: Unfortunately, the specific chemokine ligands considered by Peng et al. (e.g. CXCL9 andCXCL10) do not have 450k probes mapping to their promoters and our study also excluded ovarian cancer due to the lack of an appropriate normal reference.